A new Alzheimer’s therapy is approved in China, delivering a surprise for the field but also questions
Chinese regulators have granted conditional approval to an Alzheimer’s drug that is derived from seaweed, raising some hopes but also many questions.
No hay comentarios:
Publicar un comentario